| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | VANGUARD INDEX FDS | 2,837,100 | 297,385,000 | 32.59% | ||
| 2 | OPHTHOTECH CORP COM | 4,910,487 | 207,566,000 | 22.75% | ||
| 3 | INOGEN INC COM | 3,549,320 | 159,648,000 | 17.50% | ||
| 4 | VANGUARD INTL EQUITY INDEX F | 2,101,000 | 101,941,000 | 11.17% | ||
| 5 | CORVUS PHARMACEUTICALS INC COM | 3,154,046 | 45,734,000 | 5.01% | ||
| 6 | COLUCID PHARMACEUTICALS INC COM | 3,056,563 | 18,951,000 | 2.08% | ||
| 7 | TOBIRA THERAPEUTICS INC | 2,281,405 | 18,662,000 | 2.05% | ||
| 8 | ACCELERON PHARMA | 673,063 | 17,762,000 | 1.95% | ||
| 9 | PENUMBRA INC COM | 263,191 | 12,107,000 | 1.33% | ||
| 10 | Nabriva Therapeutics AG | 874,985 | 7,840,000 | 0.86% | ||
| 11 | INVUITY INC | 936,193 | 6,759,000 | 0.74% | ||
| 12 | WRIGHT MED GROUP N V | 4,622,032 | 5,778,000 | 0.63% | PRN | |
| 13 | HTG MOLECULAR DIAGNOSTICS IN | 1,280,185 | 3,674,000 | 0.40% | ||
| 14 | SPECTRANETICS CORP | 236,826 | 3,439,000 | 0.38% | ||
| 15 | TOKAI PHARMACEUTICALS INC | 470,946 | 2,642,000 | 0.29% | ||
| 16 | GLAUKOS CORP | 101,106 | 1,705,000 | 0.19% | ||
| 17 | XENON PHARMACEUTICALS INC | 127,563 | 892,000 | 0.10% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-16-017459, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
